
We proudly partner with Vaginal Biome Science, the biotechnology sister company to Good Clean Clinical Care, which is conducting the groundbreaking VENUS (Vaginal Ecosystem and Network in the US) study.
Launched in 2024, the VENUS study collects statistically powered microbiome data across 12 of the most common vaginal conditions diagnosed by physicians. This revolutionary combination of data points will help us to better understand both the misdiagnosis and inability to resolve many women’s health conditions.
As a sister company to Good Clean Clinical Care, your microbiome test data is interpreted through the insights gained from this and other studies conducted by VBS researchers.
Launched in 2024, the VENUS study collects statistically powered microbiome data across 12 of the most common vaginal conditions diagnosed by physicians. This revolutionary combination of data points will help us to better understand both the misdiagnosis and inability to resolve many women’s health conditions. As a sister company to Good Clean Clinical Care, your microbiome test data is interpreted through the insights gained from this and other studies conducted by VBS researchers.